Acetazolamide in vestibular migraine prophylaxis: a retrospective study

dc.contributor.authorCelebisoy, Nese
dc.contributor.authorGokcay, Figen
dc.contributor.authorKarahan, Ceyda
dc.contributor.authorBilgen, Cem
dc.contributor.authorKirazli, Tayfun
dc.contributor.authorKarapolat, Hale
dc.contributor.authorKose, Timur
dc.date.accessioned2019-10-27T11:26:06Z
dc.date.available2019-10-27T11:26:06Z
dc.date.issued2016
dc.departmentEge Üniversitesien_US
dc.description.abstractThe aim of this study is to check the efficacy of acetazolamide in the prophylaxis of vestibular migraine (VM). Treatment options in VM are mainly based on migraine guidelines. We tried to assess the efficacy of acetazolamide in these patients depending on clinical similarities with episodic ataxia type 2 and familial hemiplegic migraine responding to the drug. This is a retrospective cohort study. Among 50 patients with VM and prescribed acetazolamide 500 mg/day, 39 patients were studied as five had been lost on follow-up and six had stopped taking the drug due to side effects. Vertigo and headache frequency determined by number of attacks per month, and the severity determined by visual analog scales measured in centimeters from 0 to 10 were collected from the records. Initial reported figures for frequency and severity were compared with the results gathered after 3 months of treatment. The results were compared. Acetazolamide was effective in reducing both the frequency and severity of vertigo and headache attacks and this effect was more prominent for vertigo frequency and severity.en_US
dc.identifier.doi10.1007/s00405-015-3874-4en_US
dc.identifier.endpage2951en_US
dc.identifier.issn0937-4477
dc.identifier.issn1434-4726
dc.identifier.issue10en_US
dc.identifier.pmid26728486en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage2947en_US
dc.identifier.urihttps://doi.org/10.1007/s00405-015-3874-4
dc.identifier.urihttps://hdl.handle.net/11454/33458
dc.identifier.volume273en_US
dc.identifier.wosWOS:000382945900010en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Archives of Oto-Rhino-Laryngologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectVestibular migraineen_US
dc.subjectProphylaxisen_US
dc.subjectAcetazolamideen_US
dc.titleAcetazolamide in vestibular migraine prophylaxis: a retrospective studyen_US
dc.typeArticleen_US

Dosyalar